Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07160582 · ClinicalTrials.gov registry record · NA
Cognitive-Motor Training for AD/ADRD Prevention
A NA study, sponsored by University of Illinois at Chicago.
- Not yet
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT07160582: Clinical Trial NA study, sponsored by University of Illinois at Chicago.
NCT07160582 is a NA study that has not yet begun recruiting, run by University of Illinois at Chicago. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07160582, a NA study, has not yet begun recruiting, sponsored by University of Illinois at Chicago.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Alzheimer's disease and related dementias (AD/ADRD) greatly affect memory and daily activities in older adults. Mild Cognitive Impairment (MCI) is an early stage of dementia, affecting about 17% of older adults. People with MCI often show problems with gait and balance, which doubles their risk of falling compared to cognitively healthy peers. Falls can cause injuries, increase sedentary behavior, and reduce physical activity. This decline in activity can also speed up the progression from MCI to dementia. Exercise can help older adults make healthy lifestyle changes; however, most of the existing exercise programs focus mainly on physical movement rather than cognitive function. Therefore, the investigators developed a new program that uses computer vision and a cloud-based system to provide more scalable, engaging, and personalized cognitive-motor training for OAwMCI. The purpose of this study is to investigate the short- and long-term effects of a novel CogXergaming training (CXT) paradigm for improving the cognitive-motor function, physical activity, falls efficacy, and quality of life.
Primary Outcome
Measures changes in max excursion under dual-task conditions during the LOS test compared to the single-task.
Interventions
- BEHAVIORAL Novel CogXergaming Training
- BEHAVIORAL Exercise and Education Training Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
What is known before NCT07160582 opens enrollment
NCT07160582 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Novel CogXergaming Training is the first listed.
NCT07160582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07160582 about?
NCT07160582 is a clinical study titled "Cognitive-Motor Training for AD/ADRD Prevention". Alzheimer's disease and related dementias (AD/ADRD) greatly affect memory and daily activities in older adults. Mild Cognitive Impairment (MCI) is an early stage of dementia, affecting about 17% of older adults. People with MCI often show problems with gait and balance, which doubles their risk of f...
What is the current status of trial NCT07160582?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2026-05-01. Estimated completion is 2027-09-01.
What interventions are being tested in trial NCT07160582?
The interventions under investigation include: Novel CogXergaming Training (BEHAVIORAL), Exercise and Education Training Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07160582?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07160582's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI